AB-1005: Clinical Trials

2 trials of AB-1005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 2

Follow AB-1005: new trials by email Literature Review of AB-1005 trials Research Report on AB-1005

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
AB-1005 - Parkinson Disease
Phase 2Not yet recruitingBayer82027-01-252026-07-29
Prescriptive Infusion Algorithm (PIA)
Prescriptive Infusion Algorithm, AB-1005 - PARKINSON DISEASE (Disorder)
Phase 2Not yet recruitingAskBio Inc182026-11-012026-07-27

Conditions studied

Parkinson Disease (2)

Sponsors

AskBio Inc (1)  ·  Bayer (1)

Countries

Japan (1)  ·  United States (1)